| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 11.2 | 14.2 |
| Net income | -14.0 | -12.8 |
| EPS (diluted, $ a share) | $-0.03 | $-0.04 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -20.7% |
|---|---|
| Operating margin | -128.8% |
10-Q filed with the SEC, NASDAQ: LXRX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Lexicon Pharmaceuticals, Inc.: key numbers
- Share price
- $1.75Close, Nov 16
- Market cap
- $779M
- Shares outstanding
- 445.23MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Lexicon Pharmaceuticals, Inc.
All →Lexicon Pharmaceuticals CEO Michael Exton Buys $50K of Stock
Michael Exton, CEO, bought 30,064 shares of Lexicon Pharmaceuticals, Inc. at $1.66 a share, worth $50K in total on Nov 6, 2026. Shares held after the trade: 328,496 (+10.1%).
- Value
- $50K
- Shares
- 30,064
- Price
- $1.66
- Role
- CEO
- Holding change
- +10.1%
- Trade date
- Nov 6, 2026
Lexicon Pharmaceuticals Financial Results
Lexicon Pharmaceuticals reported Q3 2026 financial results and provided clinical updates, including the completion of enrollment for its Phase 3 SONATA-HCM study. The company also confirmed it has achieved the safety data requirements for its ZYNQUISTA NDA resubmission in type 1 diabetes.
- Term
- 3 months
“This quarter brought Lexicon into sharper focus as a cardiometabolic company and has positioned us to approach 2027 with strong momentum and multiple near-term potential catalysts and paths to value creation.”
Mike Exton, Ph.D., Lexicon’s chief executive officer and director
“As we prepare for several important milestones across our portfolio, we remain focused on investing prudently to support execution and position the Company for long-term success.”
Scott Coiante, Lexicon’s chief financial officer